Follow us on Twitter
twitter icon@FreshPatents


Polycystic Ovarian Disease patents

      

This page is updated frequently with new Polycystic Ovarian Disease-related patent applications.




 Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists patent thumbnailSpiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists
Spiroindoline derivatives, processes for their preparation and pharmaceutical compositions thereof, their use for the treatment of diseases, and their use for the manufacture of medicaments for the treatment of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selected from the group of endometriosis, uterine leiomyoma (fibroids), polycystic ovarian disease, menorrhagia, dysmenorrhea, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception, infertility and assisted reproductive therapy such as in vitro fertilization. The present application relates in particular to spiroindoline derivatives as gonadotropin-releasing hormone (gnrh) receptor antagonists..
Bayer Pharma Aktiengesellschaft


 Gonadotropin releasing hormone receptor antagonists,  the preparation thereof and pharmaceutical composition comprising the same patent thumbnailGonadotropin releasing hormone receptor antagonists, the preparation thereof and pharmaceutical composition comprising the same
Disclosed are a gonadotropin releasing hormone receptor antagonist and a pharmaceutical composition including the same, which can be useful in preventing or treating a sex hormone-related disease such as endometriosis, amenorrhea, irregular menstruation, uterine myoma, uterine fibroids, polycystic ovarian disease, lupus erythematous, hypertrichosis, precocious puberty, short stature, acne, alopecia, gonadal steroid-dependent neoplasms, gonadotropin-producing pituitary adenoma, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception, and infertility, as well as alzheimer disease.. .
Sk Chemicals Co., Ltd.


 Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists patent thumbnailSpiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists
Spiroindoline derivatives, process for their preparation and pharmaceutical compositions thereof, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selected from the group of endometriosis, uterine fibroids, polycystic ovarian disease, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception and infertility (e.g., assisted reproductive therapy such as in vitro fertilization). The present application relates in particular to spiroindoline derivatives as gonadotropin-releasing hormone (gnrh) receptor antagonists..

 Organic compounds patent thumbnailOrganic compounds
Said compound is inhibitor of aldosterone synthase and aromatase, and thus can be employed for the treatment of a disorder or disease mediated by aldosterone synthase or aromatase. Accordingly, the compound of formula i can be used in treatment of hypokalemia, hypertension, congestive heart failure, atrial fibrillation, renal failure, in particular, chronic renal failure, restenosis, atherosclerosis, syndrome x, obesity, nephropathy, post-myocardial infarction, coronary heart diseases, inflammation, increased formation of collagen, fibrosis such as cardiac or myocardiac fibrosis and remodeling following hypertension and endothelial dysfunction, gynecomastia, osteoporosis, prostate cancer, endometriosis, uterine fibroids, dysfunctional uterine bleeding, endometrial hyperplasia, polycystic ovarian disease, infertility, fibrocystic breast disease, breast cancer and fibrocystic mastopathy.

 Devices and methods for treating and/or preventing diseases patent thumbnailDevices and methods for treating and/or preventing diseases
The invention relates to a therapeutic device for the delivery of therapeutic agents, e.g. A peptide such as leuprolide, via the vagina to a female mammal.



Polycystic Ovarian Disease topics:
  • Endometrial
  • Prostate Cancer
  • Breast Cancer
  • Polycystic Ovarian Disease
  • Ovarian Disease
  • Aldosterone
  • Syndrome X
  • Restenosis
  • Osteoporosis
  • Myocardial Infarction
  • Uterine Bleeding
  • Steoporosis
  • Uterine Fibroids
  • Dysfunctional Uterine Bleeding
  • Endothelial Dysfunction


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Polycystic Ovarian Disease for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Polycystic Ovarian Disease with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.0847

    file did exist - 311

    1 - 1 - 5